Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4309962 | Surgery | 2006 | 9 Pages |
Abstract
We did not identify histologic, demographic, or molecular variables that can exclude the risk of associated lymphatic metastases reliably. Furthermore, not all predictive factors are known before the operation (eg, whether the tumor is T1a or T1b). Therefore, we recommend that SLNB be performed in all patients with clinically lymph node-negative invasive breast cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Tina J. MD, Josè M. MD,